Related Experiment Video
Updated: Jan 25, 2026

An In Vitro Approach to Photodynamic Therapy
Published on: August 17, 2018
Photodynamic therapy and neoplastic disease
1Department of Pharmacology, Wayne State University, Detroit, MI 48201.
Abstract:
The selective photosensitization of neoplastic lesions is a new modality for eradication of early tumors and palliation of more advanced disease. There is a substantial amount of information relating to modes of photodamage, and the clinical role of this form of therapy is becoming clarified. New sensitizers are being developed with a view toward an enhanced photodynamic effect, utilization of simpler light sources, and elimination of concurrent skin photosensitization. The mechanism whereby efficacious photosensitizers localize in neoplastic, as compared with normal, adjacent tissue remains to be determined, although theories have been proposed. The photosensitizing agent used in most clinical protocols in Photofrin. This product is a complex mixture of porphyrin monomers, dimers, and higher oligomers, and interpretation of biologic and photophysical data is often difficult, although this is not universally appreciated.
Insights
Photodynamic therapy uses light-sensitizing drugs to target and destroy cancer cells, offering a new treatment for early-stage tumors. Research is ongoing to improve drug delivery and minimize side effects like skin sensitivity.
Area of Science:
- Oncology
- Photochemistry
Background:
- Photodynamic therapy (PDT) is an emerging treatment for neoplastic lesions.
- It involves selective photosensitization for tumor eradication and palliation.
Purpose of the Study:
- To review the current understanding of PDT, including photodamage mechanisms and clinical applications.
- To discuss the development of new photosensitizers with improved efficacy and reduced side effects.
- To explore the unresolved mechanisms of photosensitizer localization in tumors.
Main Methods:
- Review of existing literature on PDT mechanisms, clinical data, and sensitizer development.
- Analysis of the properties of Photofrin, a common photosensitizing agent.
Main Results:
- PDT is a viable modality for early tumor eradication and palliation of advanced disease.
- New photosensitizers are being developed to enhance photodynamic effects and reduce skin photosensitization.
- The precise mechanism of selective photosensitizer localization in neoplastic tissue requires further investigation.
Conclusions:
- PDT is a promising therapeutic approach with evolving applications.
- Further research into photosensitizer mechanisms and development is crucial for optimizing PDT.
- Understanding photosensitizer localization is key to improving treatment selectivity and efficacy.
Related Concept Videos
Gene Therapy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Group Therapy
Psychodynamic Therapy
Humanistic Therapy
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

